Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
Launched by UNIVERSITY OF ROCHESTER · Jul 16, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether sending daily text message reminders can help men recover better from urinary leakage after prostate surgery. Specifically, it looks at how these reminders to do pelvic floor exercises—exercises that strengthen the muscles controlling urine flow—might improve symptoms measured by a standard incontinence score. The goal is to see if these messages can make a difference compared to men who do not receive reminders.
Men who are planning to have prostate surgery, such as prostate removal or a procedure to remove part of the prostate, and who are patients at URMC Urology may be eligible to join. Participants must be 18 or older, able to read and write in English, and have a mobile phone that can receive text messages. If they agree to take part, they will receive daily text reminders to do pelvic floor exercises and will complete questionnaires sent by text to track their progress. This study has not started recruiting yet, but it aims to find an easy way to support men’s recovery after prostate surgery.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
- • 2. Patient of URMC Urology
- • 3. Adult male 18 years of age and older
- • 4. Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
- • 5. Has access to a mobile device capable of receiving automated text messages.
- • 6. Willing to receive text messages and to complete questionnaires via SMS text.
- • 7. Willingness to participate and able to provide informed consent.
- Exclusion Criteria:
- • 1. Less than 18 years of age
- • 2. Unable to send and receive SMS texts
- • 3. Unable to read, write, and speak English
- • 4. Catheter dependency
- • 5. Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
- • 6. In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.
About University Of Rochester
The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported